Cargando…

A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy

Patient: Male, 39-year-old Final Diagnosis: Medullary thyroid carcinoma Symptoms: Painful left latero-cervical mass of 2.5 cm Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic • Surgery OBJECTIVE: Rare disease BACKGROUND: Medullary thyroid carcinoma is a rare tumor and repre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Licata, Lorena, Di Fidio, Cristina A., Vacante, Marco, Basile, Francesco, Biondi, Antonio, Richiusa, Pierina, Gurrera, Alessandra, Ciuni, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475495/ https://www.ncbi.nlm.nih.gov/pubmed/36088532 http://dx.doi.org/10.12659/AJCR.935207

Ejemplares similares

Serum calcitonin negative Medullary thyroid carcinoma
por: Sand, Michael, et al.
Publicado: (2006)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Yue, Wenliang, et al.
Publicado: (2022)

Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes
por: Fan, Yi, et al.
Publicado: (2022)

The Difficulty of Post-Operative Surveillance of Calcitonin Negative Medullary Thyroid Cancer
por: Skutnik, Emily, et al.
Publicado: (2021)

The Liquid Biopsy in the Management of Colorectal Cancer: An Overview
por: Vacante, Marco, et al.
Publicado: (2020)

Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence
por: Vacante, Marco, et al.
Publicado: (2020)

Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?
por: Daumerie, Chantal, et al.
Publicado: (2013)

Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
por: Gambardella, Claudio, et al.
Publicado: (2019)

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
por: Kim, Sun Jung, et al.
Publicado: (2021)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2021)

ODP466 Case of Sporadic Medullary Thyroid Cancer Detected by Serum Calcitonin Measurement
por: Juneau, Andrea Kate, et al.
Publicado: (2022)

Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2020)

Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review
por: Gambardella, Claudio, et al.
Publicado: (2019)

Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance
por: Rafaey, Wania, et al.
Publicado: (2022)

Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer
por: Andrade, Fernanda, et al.
Publicado: (2019)

Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology
por: Jassal, Karishma, et al.
Publicado: (2022)

Calcitonin Non-Secreting Mixed Medullary-Papillary Thyroid Carcinoma: Report of a Rare Entity and Therapeutic Implications
por: Oleinikov, Kira, et al.
Publicado: (2021)

Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma
por: DE CREA, C., et al.
Publicado: (2014)

Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
por: Chen, Li, et al.
Publicado: (2020)

The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels
por: Araz, Mine, et al.
Publicado: (2023)

Medullary thyroid carcinoma and duodenal calcitonin-secreting neuroendocrine tumour: more than coincidence?
por: Huguet, I, et al.
Publicado: (2013)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
por: Batista, Rafael Loch, et al.
Publicado: (2013)

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
por: Fugazzola, L., et al.
Publicado: (2020)

Combining serum calcitonin, carcinoembryonic antigen, and neuron‐specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma
por: Ye, Liuqing, et al.
Publicado: (2020)

No calcitonin change in a person taking dulaglutide diagnosed with pre‐existing medullary thyroid cancer
por: Sherman, S. I., et al.
Publicado: (2018)

Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer
por: KARTAL BAYKAN1, Emine, et al.
Publicado: (2021)

Does pretreatment elevated calcitonin level cause the poor prognosis in patients with medullary thyroid cancer?
por: Zhang, Han, et al.
Publicado: (2022)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
por: Jiao, Zan, et al.
Publicado: (2022)

Diagnostic performance evaluation of post-operative serum calcitonin (CT) levels as a factor for good prognosis in medullary thyroid carcinoma (MTC)
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2013)

MON-329 Calcitonin-Secreting Neuroendocrine Tumor Raising Concern for Medullary Thyroid Carcinoma in a Patient with Thyroid Nodules
por: Del Castillo, Ma. Dolores, et al.
Publicado: (2019)

Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules
por: Broecker-Preuss, Martina, et al.
Publicado: (2023)

Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration
por: Marques, Bernardo, et al.
Publicado: (2020)

SAT560 A Case of Medullary Thyroid Carcinoma with Increasing Carcinoembryonic Antigen and Stable Calcitonin Levels
por: Youssef, Kerolos N, et al.
Publicado: (2023)

Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis
por: Sparano, Clotilde, et al.
Publicado: (2023)

Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer
por: Chorny, Joseph A, et al.
Publicado: (2018)

The dilemma of routine testing for calcitonin thyroid nodule’s patients to detect or exclude medullary carcinoma: one single negative test should be valuable as rule-out strategy to avoid further calcitonin measurements over time
por: Trimboli, Pierpaolo, et al.
Publicado: (2022)

Editorial: Recent Advances in Thyroid Surgery
por: Scerrino, Gregorio, et al.
Publicado: (2022)

Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma
por: Bojunga, J, et al.
Publicado: (2001)

Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery
por: Schott, Matthias, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_n85dlul8tik71klolloreqjsii